The global medicines supply chain
The global medicines supply chain is vulnerable to disruptions that lead to drug shortages as well as increases in substandard and counterfeit medicines. A strong supply chain ensures patients receive the medicines needed when they are needed, they work as they should and do not cause unnecessary harm. This builds trust.
We are working to improve supply chain resilience by increasing transparency into potential risks through initiatives such as our Medicine Supply Map – an early detection warning system to help predict drug shortages. Through our partnerships and stakeholder engagement we are facilitating greater coordination among governments and multilateral bodies and we are also working to diversify where medicines are made so that manufacturing hubs are more evenly distributed across the globe, reducing the risk of overly relying on a few regions.
Harnessing information to inform effective action to reduce vulnerabilities and prevent or mitigate disruptions in the global supply of quality medicines.
Are my medicines at risk of a shortage?
USP did an analysis of structured product labels approved for use in the U.S. Read the blog for the importance of this information within the pharmaceutical supply chain.
Improving the Supply Chain with Continuous Manufacturing: Pharmaceutical Solid Dosage Form
This four-week online course from USP and Rutgers University is for management and technical personnel seeking to identify the supply chain benefits and regulatory and operational requirements for PCM.
Building greater resilience in the supply chain
Key elements to building a more resilient supply chain.